{"lastName":"Rich","objectUrn":"urn:li:member:455615890","geoRegion":"Vancouver, British Columbia, Canada","fullName":"Jamie Rich","firstName":"Jamie","currentPositions":[{"companyName":"Zymeworks Inc.","title":"Senior Director, Technology | ADC Therapeutic Development","tenureAtCompany":{"numYears":8,"numMonths":3},"companyUrnResolutionResult":{"employeeCountRange":"201-500","headquarters":{"geographicArea":"BC","country":"Canada","city":"Vancouver","postalCode":"V6H 3V9","line1":"540 - 1385 West 8th Ave"},"website":"http:\/\/www.zymeworks.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/zymeworks\/","industry":"Biotechnology Research"},"startedOn":{"month":9,"year":2023},"companyUrn":"urn:li:fs_salesCompany:126235"},{"companyName":"Zymeworks Inc.","title":"Director, Technology | ADC Therapeutic Development","tenureAtCompany":{"numYears":8,"numMonths":3},"companyUrnResolutionResult":{"employeeCountRange":"201-500","headquarters":{"geographicArea":"BC","country":"Canada","city":"Vancouver","postalCode":"V6H 3V9","line1":"540 - 1385 West 8th Ave"},"website":"http:\/\/www.zymeworks.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/zymeworks\/","industry":"Biotechnology Research"},"startedOn":{"month":3,"year":2022},"companyUrn":"urn:li:fs_salesCompany:126235"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABsoJZIBUe8nWMPXKz3pzsX7d4eevANGqF0,NAME_SEARCH,7H0F)","projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"degree":"Doctor of Philosophy (Ph.D.)","schoolUrn":"urn:li:fs_salesSchool:6455","eduId":307998706,"school":"urn:li:fs_salesSchool:6455","fieldsOfStudy":["Organic Chemistry"],"schoolName":"University of Alberta"}],"skills":[{"numOfEndorsement":0,"name":"Biotechnology"},{"numOfEndorsement":0,"name":"Protein Chemistry"},{"numOfEndorsement":0,"name":"Antibodies"},{"numOfEndorsement":0,"name":"Biochemistry"},{"numOfEndorsement":0,"name":"Drug Development"}],"numOfConnections":686,"patents":[],"headline":"Senior Director, Technology | ADC Therapeutic Development","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/richjamie","organizations":[],"location":"Vancouver, British Columbia, Canada","publications":[],"positions":null,"posts":[{"createdAt":1714667040000,"insightId":"221923e7-52bb-4317-98a8-f54352d0bd16","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D5627AQEGnTg_EcFj-g\/articleshare-shrink_800\/0\/1714667026006?e=1717977600&v=beta&t=ylElzpSt7nvAHH9To085k_g3t9oUyusrX8WVBVHmwp4","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D5627AQEGnTg_EcFj-g\/articleshare-shrink_800\/0\/1714667026006?e=1717977600&v=beta&t=ylElzpSt7nvAHH9To085k_g3t9oUyusrX8WVBVHmwp4"}]},"description":"Cover Image ZD060519 is a camptothecin-based topoisomerase 1 inhibitor designed for antibody drug conjugates. This payload was selected from a library of \u223c100 analogs for its optimal potency, permeability, and other drug-like characteristics....","resolvedUrl":"https:\/\/aacrjournals.org\/mct\/issue\/23\/5","title":"Issues"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":128},{"type":"PRAISE","count":21},{"type":"EMPATHY","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7191834842106363904","threadUrn":"urn:li:activity:7191834842106363904","reactionsCount":152,"commentsCount":8,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7191834748795719680","message":{"attributes":[],"text":"We are excited to see our topoisomerase inhibitor ADC payload manuscript featured on this month's cover of Molecular Cancer Therapeutics! Thanks to everyone involved!"},"entityUrn":"urn:li:share:7191834748795719680"}}},{"createdAt":1712340240000,"insightId":"c198d8d4-8932-45c3-83f8-d21d9f54bbca","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7181804051821461505,7182075657596645376)","threadUrn":"urn:li:ugcPost:7181804051821461505","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Welcome Alex!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7181804051821461505"}}},{"createdAt":1710851520000,"insightId":"f5862e48-143a-43d5-8d2a-43d960657b9c","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7174508468291207171,7175831457414750208)","threadUrn":"urn:li:activity:7174508468291207171","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congrats Ethan"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7174508468291207171"}}}]}